Screener
Sionna Therapeutics SION Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 16,831 | 19,120 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 45 | 45 |
| Additional paid-in capital | 571,380 | 562,602 |
| Accumulated other comprehensive (loss) income | (84) | 540 |
| Accumulated deficit | (283,133) | (256,354) |
| Total stockholders’ equity | 288,208 | 306,833 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's common stock?
- Sionna Therapeutics (SION) reported common stock of 500M in Q1 2026.
- How has Sionna Therapeutics's common stock changed year-over-year?
- Sionna Therapeutics's common stock decreased by 0.0% year-over-year, from 500M to 500M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Sionna Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude